ESC 365 - Disease progression and outcomes in patients with transthyretin amyloid cardiomyopathy receiving tafamidis

Open Access

Disease progression and outcomes in patients with transthyretin amyloid cardiomyopathy receiving tafamidis

Session: Expanding insights from heart failure registries and surveys

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor M. Fontana (London, GB)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Professor Marianna Fontana

University College London, London (United Kingdom of Great Britain & Northern Ireland)

68 presentations

39 followers

5 more presentations in this session

Age-related disparities in heart failure: insights into clinical profiles, treatment gaps, and outcomes from a multi-center and multi-ethnic study

Speaker: Doctor A. Koh (Kuching, MY)

Non-conventional parameters from holter ECG: a promising tool for heart failure risk stratification

Speaker: Doctor S. Duca (Iasi, RO)

The epidemiology of heart failure in Hungary: basic data and temporal trends from the Hungarian nationwide epidemiological study (HF-EPI-HUN) over a 15-year period (2009-2023)

Speaker: Doctor R. Sepp (Szeged, HU)

Evaluating survival outcomes across NT-proBNP levels and introduction of a high alert pathway: an island wide experience

Speaker: Doctor A. Henry (St Helier, JE)

Clinical characteristics, management trends, and outcomes of acute heart failure in Korea: Insights from the SMILE-HF Registry

Speaker: Associate Professor S. Lee (Seoul, KR)

Access the full session

Expanding insights from heart failure registries and surveys

Speakers: Professor M. Fontana, Doctor A. Koh, Doctor S. Duca, Doctor R. Sepp, Doctor A. Henry...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources